Back to Browse Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 3 » Issue 3

Mechanisms of improvement of respiratory failure in patients with COPD treated with NIV

Authors Annabel H Nickol, Nicholas Hart, Nicholas S Hopkinson, Carl-Hugo Hamnegård, John Moxham, et al

Published 12 September 2008 Volume 2008:3(3) Pages 453—462


Annabel H Nickol1,2, Nicholas Hart1,3, Nicholas S Hopkinson1, Carl-Hugo Hamnegård4, John Moxham5, Anita Simonds1, Michael I Polkey1

1Respiratory Muscle Laboratory, Royal Brompton Hospital, London, UK; 2Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford, UK; 3The Lane Fox Unit, St Thomas’ Hospital, London, UK; 4Department of Pulmonary Medicine and Clinical Physiology, Sahlgrenska University, Gotenborg, Sweden; 5Respiratory Muscle Laboratory, King’s College London School of Medicine, King’s College Hospital, London, UK

Background: Noninvasive ventilation (NIV) improves gas-exchange and symptoms in selected chronic obstructive pulmonary disease (COPD) patients with hypercapnic respiratory failure. We hypothesized NIV reverses respiratory failure by one or all of increased ventilatory response to carbon-dioxide, reduced respiratory muscle fatigue, or improved pulmonary mechanics.

Methods: Nineteen stable COPD patients (forced expiratory volume in one second 35% predicted) were studied at baseline (D0), 5–8 days (D5) and 3 months (3M) after starting NIV.

Results: Ventilator use was 6.2 (3.7) hours per night at D5 and 3.4 (1.6) at 3M (p = 0.12). Mean (SD) daytime arterial carbon-dioxide tension (PaCO2) was reduced from 7.4 (1.2) kPa to 7.0 (1.1) kPa at D5 and 6.5 (1.1) kPa at 3M (p = 0.001). Total lung capacity decreased from 107 (28) % predicted to 103 (28) at D5 and 103 (27) % predicted at 3M (p = 0.035). At D5 there was an increase in the hypercapnic ventilatory response and some volitional measures of inspiratory and expiratory muscle strength, but not isolated diaphragmatic strength whether assessed by volitional or nonvolitional methods.

Conclusion: These findings suggest decreased gas trapping and increased ventilatory sensitivity to CO2 are the principal mechanism underlying improvements in gas-exchange in patients with COPD following NIV. Changes in some volitional but not nonvolitional muscle strength measures may reflect improved patient effort.

Keywords: COPD; hypercapnic respiratory failure; NIV; pulmonary mechanics; ventilatory drive

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Readers of this article also read:

Efficacy of a trunk orthosis with joints providing resistive force on low-back load in elderly persons during static standing

Katsuhira J, Matsudaira K, Yasui T, Iijima S, Ito A

Clinical Interventions in Aging 2015, 10:1413-1420

Published Date: 1 September 2015

Pituitary dysfunction following traumatic brain injury: clinical perspectives

Tanriverdi F, Kelestimur F

Neuropsychiatric Disease and Treatment 2015, 11:1835-1843

Published Date: 27 July 2015

Activity of daptomycin- and vancomycin-loaded poly-epsilon-caprolactone microparticles against mature staphylococcal biofilms

Santos Ferreira I, Bettencourt AF, Gonçalves LMD, Kasper S, Bétrisey B, Kikhney J, Moter A, Trampuz A, Almeida AJ

International Journal of Nanomedicine 2015, 10:4351-4366

Published Date: 7 July 2015

Major depressive disorder: mechanism-based prescribing for personalized medicine

Saltiel PF, Silvershein DI

Neuropsychiatric Disease and Treatment 2015, 11:875-888

Published Date: 31 March 2015

Quality of life of patients with schizophrenia treated in foster home care and in outpatient treatment

Mihanović M, Restek-Petrović B, Bogović A, Ivezić E, Bodor D, Požgain I

Neuropsychiatric Disease and Treatment 2015, 11:585-595

Published Date: 5 March 2015

Anti-CD30-targeted gold nanoparticles for photothermal therapy of L-428 Hodgkin’s cell [Erratum]

Qu X, Yao C, Wang J, Li Z, Zhang Z

International Journal of Nanomedicine 2013, 8:1635-1636

Published Date: 26 April 2013

Tissue regeneration as next-generation therapy for COPD – potential applications

Shunsuke Ohnishi, Noritoshi Nagaya

International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:509-514

Published Date: 5 December 2008